chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 11:46 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 11:46 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 40.13 for dose administered on 15-Apr-2021.  No concomitant medications were reported.  Batch number 044B21A underwent temperature excursion on 15-Apr-2021 with temperature 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 06-Apr-2021 and beyond use date for the vial was reported as 09-May-2021. Product moved to clinic on 15-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Started vomiting and has had the dry heaves since about 1:00pm central time.
Muscle and body aches; Nausea; Decreased appetite; Gastrointestinal upset; Fatigue; body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 12:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 30Apr2021 at 22:00, the patient experienced muscle and body aches, nausea, decreased appetite, gastrointestinal upset and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle and body aches, nausea, decreased appetite, gastrointestinal upset and fatigue was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recv vaxs on 7/29/98; on 8/14/98 pt exp knee, ankle, & hand swelling.  Swelling began in knees progressed to ankles then hands; slight swelling & tenderness.
Wednesday afternoon, 3:15pm I received the shot in my left arm. Wednesday I felt achy tight muscles in my neck on my traps, down the right side of my back, and into my right calf. I am an athlete and have regular issues with this path of muscles. Thursday morning and most of the day, my left deltoid was so sore I couldn't lift my left arm. In the evening, I was working on the computer and my left elbow was rubbing on the desk and getting sore, so eventually I looked down to notice on the inside of my left arm above the elbow I had blisters forming. I touched them and they felt tingly and itchy like when I get a cold sore on my lips. It was a dried skin patch with blisters. Friday by midday 6 blisters had formed. 3 in a curved line, 2 small ones inside the curve and one above it. Friday night at 10pm, the 3 were full blisters with brown colored liquid in them. Not clear like my cold sores get. Monday, August 16th, the blisters burst or were scraped off at some point during activity and turned into red scabs. For the next several days, they were healing. Tuesday night, August 24th I noticed them again being extremely itchy. I wanted to scratch them, but when i touched them, they hurt like I was touching an open wound. From August 24th, until today, August 31st, there hasn't been much change, they are still very itchy. I have put Abreva on them. My mother who was a pediatric ICU nurse for 30 years said they look like shingles. I have not been to a doctor to have them looked at.
1. Left arm became red, itchy and swelling.  2. Blood pressure become lower than average  3. Pain at the muscle of left under arm .
Within 30 minutes, developed tingling to right arm and tingling/numbness to fingertips of right hand. The pins needles sensations progressed down to right leg working its way to top of head(this felt like an electrical sensation shooting across the top of my scalp) then proceeding down my spine crossing to left arm and then down left leg. This took about an hour to progress across the body. Once this happened, I started having the sensations at random sites on my body- no pattern.  within 2 hours, developed sharp, stabbing pain to right lower back. episode brief but painful.  within 4 hours, developed tension headache- lots of pressure across my head. 6 hours developed deep itching to chest/torso/back. leg vibrations occurred briefly while laying in bed.  12 hours woke up with sweat drenching my chest, abdominal cramps, lower back pain, spotting. Right arm extremely painful.   Headadche lasted for 2 days, sensations occurred consistently for 2 days, abdominal cramps and spotting lasted for 3 days.   developed exercise fatigue, palpitations within 5 days of vaccination. heart murmur detected 21 days after vaccination. continue to have pins/needles sensations to this day- random.
4/30/19 Patient had itching on back of right thigh, noticed 3-4 raised areas. On 5/1/19 patient noticed 12-15 more raised areas on right thigh and had Temperature of 101 degrees F. On 5/2/19 Supervisor and Employee Health RN notified and at that time patient told RN that both of her children had similar reactions following varicella vaccination. On 5/2/19 patient was sent to an Occupational Health facility for evaluation and treatment. Diagnosed with shingles, no confirmatory testing done. Valtrex prescribed. On 5/4/19 patient reported itching and swelling resolved and crusting noted.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022) and NO ADVERSE EVENT (No adverse event) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022).    No concomitant medication information was reported. Patient received half dose. The vial was initially stored in refrigerator on 04-Jun-2022. The vial did not undergo any temperature excursions. No treatment information was reported.
Severe nausea, some vomiting, severe headache, chills/sweating, fever, body aches, dizzy upon standing. All except the dizziness went away 24 hours after onset. Dizziness remained in effect for another day.
Given injection around 10 AM on 09/26/22, at 9pm side effects started.  Rigors, temp at highest 103.6 hovered around 102.4 (this is with Tylenol and motrin on board)  Symptoms lasted 3 days.  Then as per with the other doses of the vaccine my fasting sugar went to 330(which actually wasn't as high as previous covid vaccinations ). I was more prepared gave self slidding scale homolog insulin.  I gave last dose of insulin on Monday 10/3/2022. After talking with physician we increased my glipizide to 5 mg in morning and 2.5 mg in evening.  So far my fasting glucose hovers around 130-140 with nights around 150 to 170.  This usually last for 2-3 months then I become "normal" again.
Fever, Chills, headache, sore lymph-nodes under both armpits
Information has been received through the Merck pregnancy registry through a physician concerning a 17 year old female with a history of an abnormal Papanicolaou smear followed by a normal Papanicolaou smear who on 31-JUL-2007 was vaccinated with her first dose of Gardasil (Lot # 657622/0388U).  On 08-NOV-2007, the patient was vaccinated with her second dose of Gardasil (Lot # 657868/0523U).  Concomitant therapy included albuterol inhaler, as needed.  Subsequently, the patient found out she was pregnant (LMP approximately 31-OCT-2007).  The patient is currently experiencing congestion and a sore throat.  The patient sought unspecified medical attention with an office visit.  Additional information has been requested.
Within 2 days after vaccine experiencing severe diarrhea, abdominal cramping and I started passing blood in my bowels. Over the weeks the blood became worse, had a Colonoscopy, I was diagnosed with ulcerative colitis. I can't recover from this. Unfortunately, I will be on medication for the rest of my life, no cure.
Diarrhea; A spontaneous report was received from a female consumer concerning a 81-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced diarrhea.  The patient's medical history was not provided. The patient current condition included collagenous colitis. No relevant concomitant medications were reported.  On 30 Jan 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 2 Feb 2021, the patient experienced diarrhea. Treatment for the event included pepto bismol.  Action taken with mRNA-1273 in response to the event was not provided.  The outcome for the event diarrhea was unknown.; Reporter's Comments: This case concerns a 81-year-old female patient, with a relevant underlying condition of collagenous colitis, who experienced a non-serious unexpected event of diarrhea. The event occurred approximately 3 days after first dose of mRNA-1273, lot unknown. The event of herpes simplex occurred 2 days after first dose of mRNA-1273, lot # 013L20A. Treatment for the event included pepto bismol. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded. Patient's underlying collagenous colitis is considered a significant confounder.
Weakness and constant pain at left arm injection site. Massaging the injection site doesn't relieve the symptoms.
fever to 101 from a few hrs p/vax x 3d then fever to 104; went to ER & OM dx'd; 3rd dose of vax with held;
This spontaneous report was received from a nurse via a company representative referring to a 42 year old female patient. The patient's concurrent conditions included hereditary spherocytosis and autoimmune thyroiditis. The patient's medical history included splenectomy. The patient's concomitant therapies and past drug reactions/allergies were not reported. On 22-JAN-2018, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # N027770 with expiration date: 02-FEB-2019 in her left arm (strength, dose and route were not reported) for post-splenectomy (prophylaxis). On 23-JAN-2018, 24 hours after the vaccination, the patient developed symptoms of severe chills, fever, arthralgia and edema of the left arm at the site of the injection. On 25-JAN-2018, the patient went to see the reporting physician and was treated with MEDROL DOSE PAK for her symptoms, and was instructed to follow up with her primary care physician within one week. The outcome of severe chills, fever, arthralgia and edema of the left arm at the site of the injection was unknown at the time of the report. The reporter did not assess a causal relationship between the aforementioned events and PNEUMOVAX 23.
Fever on 10/14/09 and difficulty breathing onset 10/14/09 for 1 days. Symptoms has since resolved.
After they gave me the shot, I felt electric in my blood. All through my body I felt electricity in my blood, lightheaded, weak. I had to sit for 2 hours. Within 4 hours after shot my lower legs was weak and felt like I had rubber bands on my legs. Over the couple weeks the feeling moved up. Migraines, fatigue, shortness of breathe.  Doctor says it may be fiber-neuropathy.
5 raised bumps around the injection site; injection site Itchy; This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th May 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 28th May 2019, 4 days after receiving Shingrix, the patient experienced injection site rash and injection site itching. On an unknown date, the outcome of the injection site rash and injection site itching were not recovered/not resolved.   It was unknown if the reporter considered the injection site rash and injection site itching to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient received their Shingrix intramuscularly, on left arm. At the day of reporting the patient developed 5 raised bumps around the injection site that were slightly itchy. The reporter declined to provide any patient identifiers.  Lot number/expiry date unknown.
allergic reaction; rash between buttocks and legs; This is a spontaneous report from a non-contactable consumer reported for a patient. A female patient of an unknown age received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unknown), via an unknown route of ministration on an unknown date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. On an unknown date, the patient experienced allergic reaction some days after vaccination, she had a rash between buttocks and legs. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Had Varivax on 4-1 Now with fever and swelling; left arm swollen trice  P 1cm pink approximately central red pustule - Local immunization reaction
This spontaneous report as received from a consumer refers to herself, a 54 year old female patient, with drug reactions and allergies reported to amoxicillin, NAPROSYN and TORADOL. On 19-MAR-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiration date and route of administration were not reported) in the arm. There was no concomitant medication reported. On 20-MAR-2013, the patient experienced a headache and nausea. The patient did not seek medical attention. No treatment was received. The outcome of headache and nausea was unknown. Additional information is not expected.
Narrative: Severity listed as 'severe' by provider - history of Guillain Barre Syndrome. Historical, entered 8/26/22.
This literature marketed report as received from an other health professional refers to four patients of unknown age. On an unknown date the patients were vaccinated with pneumococcal vaccine (manufacturer unknown) for prophylaxis. On an unknown date the patients experienced adverse event. The outcome of adverse event was unknown. The reporter considered adverse event to be related to pneumococcal vaccine (manufacturer unknown). This is one of several reports derived from the same literature (linked reports MARRS # 1709USA000318, 1709USA000319, 1708USA012768). Sender's Comments: US-009507513-1709USA000319: US-009507513-1708USA012768: US-009507513-1709USA000318.
Nov 9 started dry cough, sore throat, fatigue, aching Nov 18,  still sick, mild fever >100, developed pink eye infection Dec 13 sore throat, dry cough,  Dec 21 developed wet cough, mild fever >100, throat sore, fatigued, aches Jan 4 still wet coughing, scratchy throat, sinus now draining (had not done so prior)
Rec'd H1N1 vaccine 12/1/09. Pre-screen questionnaire did not indicate any illness. By later in the evening had acid stomach and vomited x 5 Mon. PM. Then developed S.O.B. and coughing. Unable to eat. Went to doctor 12/4/09.
Since I was traveling I was testing, I tested negative on Wednesday, Thursday and Friday. I had a cough that kept me up all night on Friday that went away on Saturday, the same day that I tested positive for COVID-19. I had traveled for a wedding and my brother is a doctor and called me in a prescription for PAXLOVID. I started taking it immediately. I tested negative after a few days but I am now in the rebound stage of COVID-19.
Patient was 4 months shy of turning 18 and should not have received flublok yet. No adverse reactions are known, just the wrong vaccine given
Received the vaccine at 1100 that day, symptoms began at 1400. She bagan to have pain in her right groin region that spread to her posterior right hip that was progressively worsening. Pain 5/10, sharp. Feels like leg is going to give out. Also has increase in hot flashes.
PT CALLED TO REPORT PAIN AT INJECTION SITE, FEVERS (DID NOT MEASURE TEMP WITH A THERMOMETER) AND DIZZINESS.  HAS BEEN RESTING IN BED, TAKING ADVIL PRN, AND PUSHING FLUIDS.  DENIES CONCURRENT FLULIKE SYMPTOMS.
Day following the first dose I had a migraine and injection site pain as well as difficulty breathing symptoms went away in about 2 weeks  Day following second dose I had a migraine and injection site pain as well as difficulty breathing and a rapid heart beat . Breathing troubles and chest pain are still present
Systemic: Tingling (specify: facial area, extemities)-Medium, Error: Wrong Route (SC, IM, etc.), Additional Details: tingling of arm down to fingers
This spontaneous report as received from a registered nurse refers to a 12 months old male patient. Medical history and current conditions were not reported. On 20-FEB-2014, the patient was vaccinated with VARIVAX (Merck) lot # reported as J006106, expiration date: 17-MAY-2015 (route and dose were not reported) that was improperly stored on 04-SEP-2012, 06-NOV-2012, 21-MAR-2013 and 07-AUG-2014. The cumulative excursions were supported. Concomitant medication was not reported. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Pt presented to facility with fever, altered mental status, and seizures. Was diagnosed with meningoencephalitis. An exhaustive evaluation was done to determine the etiology of the meningoencephalitis without any clear cause. The only significant events include an antecedant upper respiratory infection prior to hospitalization and the anthrax vaccine 2 months before. He was dicharged to a rehabiliation facility a following a 1 month hospital stay.
My granddaughter kept complaining about pain in her right arm from the vaccination, and when I looked at her arm this morning, it's all swollen, red and welped up like a bee sting.
is red and itchy; swelling around where shot; is red and itchy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021 and was forwarded to Moderna on 07-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (is red and itchy), VACCINATION SITE SWELLING (swelling around where shot) and VACCINATION SITE ERYTHEMA (is red and itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history reported).   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (is red and itchy), VACCINATION SITE SWELLING (swelling around where shot) and VACCINATION SITE ERYTHEMA (is red and itchy). At the time of the report, VACCINATION SITE PRURITUS (is red and itchy), VACCINATION SITE SWELLING (swelling around where shot) and VACCINATION SITE ERYTHEMA (is red and itchy) outcome was unknown.            Treatment medication included topical Benadryl cream.
I can't read the Lot number of 2nd vaccine.  I'm on blood thinners.  I went for INR blood test on 03/01/2021.  Received a phone call the nest day, 03/02/2021 that my INR was a 5.5.  I'm suppose to be between a 2.0-3.0.  Never has my INR been this high.  My doctor me not to take my blood thinner for the next 3 nights & to be retested on Friday, 03/05/2021.  Was told vaccine could have raised my INR.  I feel this is going to be the start of going for blood tests to get me back into range I need to be in.
Pt started with normal muscle soreness post vaccination for about three days.  Muscle pain then began to radiate down the arm and patient also started experiencing numbness an tingling in her forth and fifth finger. Patient was here in the office today and deltoid muscle is still tender to palpation.